Renoprotective effects of dulaglutide in patients with T2DM and CKD
Crossref DOI link: https://doi.org/10.1038/s41581-018-0055-x
Published Online: 2018-08-31
Published Print: 2018-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sorensen, Charlotte M.
Holst, Jens J.
Text and Data Mining valid from 2018-08-31
Article History
First Online: 31 August 2018
Competing interests
: J.J.H. serves as a consultant for Novo Nordisk A/S and Merck Sharp & Dohme (MSD). C.M.S. declares no competing interests.